Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Should You Follow the Smart Money Stampede Out of Equity One, Inc. (EQY)?

Is Equity One, Inc. (NYSE:EQY) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research. Hedge funds spend millions of dollars on Ivy League graduates, expert networks, and get tips from industry insiders. They fail miserably sometimes but historically their consensus stock picks outperformed the market after adjusting for known risk factors.

Equity One, Inc. (NYSE:EQY) was in 10 hedge funds’ portfolios at the end of September. EQY shareholders have witnessed a decrease in enthusiasm from smart money lately. There were 18 hedge funds in our database with EQY holdings at the end of the previous quarter. At the end of this article we will also compare EQY to other stocks including Neurocrine Biosciences, Inc. (NASDAQ:NBIX), Grupo Aeroportuario del Sureste (ADR) (NYSE:ASR), and Guidewire Software Inc (NYSE:GWRE) to get a better sense of its popularity.

Follow Equity One Inc. (NYSE:EQY)
Trade (NYSE:EQY) Now!

At Insider Monkey, we’ve developed an investment strategy that has delivered market-beating returns over the past 12 months. Our strategy identifies the 100 best-performing funds of the previous quarter from among the collection of 700+ successful funds that we track in our database, which we accomplish using our returns methodology. We then study the portfolios of those 100 funds using the latest 13F data to uncover the 30 most popular mid-cap stocks (market caps of between $1 billion and $10 billion) among them to hold until the next filing period. This strategy delivered 18% gains over the past 12 months, more than doubling the 8% returns enjoyed by the S&P 500 ETFs.

investing, investment, real, risk, market, loan, banking, business, sale, home, crash, loss, danger, problems, despair, credit, falling, gamble, model, housing, economy,

Brian A Jackson/

How are hedge funds trading Equity One, Inc. (NYSE:EQY)?

Heading into the fourth quarter of 2016, a total of 10 of the hedge funds tracked by Insider Monkey held long positions in this stock, a 44% fall from one quarter earlier. Below, you can check out the change in hedge fund sentiment towards EQY over the last 5 quarters, which spiked in the first-half of the year but gave all of those gains back in Q3. So, let’s examine which hedge funds were among the top holders of the stock and which hedge funds were making big moves.


According to Insider Monkey’s hedge fund database, Millennium Management, one of the 10 largest hedge funds in the world, has the most valuable position in Equity One, Inc. (NYSE:EQY), worth close to $37.5 million. The second largest stake is held by Eduardo Abush of Waterfront Capital Partners, with a $26.3 million position; 3.8% of its 13F portfolio is allocated to the stock. Other peers with similar optimism encompass Glenn Russell Dubin’s Highbridge Capital Management, Greg Poole’s Echo Street Capital Management, and Michael Swotes’ Castle Ridge Investment Management. We should note that none of these hedge funds are among our list of the 100 best performing hedge funds which is based on the performance of their 13F long positions in non-microcap stocks.

Judging by the fact that Equity One, Inc. (NYSE:EQY) has faced declining sentiment from hedge fund managers, it’s safe to say that there lies a certain “tier” of hedgies that decided to sell off their full holdings heading into Q4. Interestingly, Benjamin A. Smith’s Laurion Capital Management said goodbye to the largest position of all the investors monitored by Insider Monkey, worth about $4.3 million in stock, and Matthew Hulsizer’s PEAK6 Capital Management was right behind this move, as the fund cut about $2.7 million worth of shares.

Let’s check out hedge fund activity in other stocks similar to Equity One, Inc. (NYSE:EQY). We will take a look at Neurocrine Biosciences, Inc. (NASDAQ:NBIX), Grupo Aeroportuario del Sureste (ADR) (NYSE:ASR), Guidewire Software Inc (NYSE:GWRE), and Ubiquiti Networks Inc (NASDAQ:UBNT). This group of stocks’ market values are closest to EQY’s market value.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
NBIX 39 635917 0
ASR 9 38120 1
GWRE 22 118946 5
UBNT 15 272438 1

As you can see these stocks had an average of 21 hedge funds with bullish positions and the average amount invested in these stocks was $266 million. That figure was $93 million in EQY’s case. Neurocrine Biosciences, Inc. (NASDAQ:NBIX) is the most popular stock in this table. On the other hand Grupo Aeroportuario del Sureste (ADR) (NYSE:ASR) is the least popular one with only 9 bullish hedge fund positions. Equity One, Inc. (NYSE:EQY) is not the least popular stock in this group but hedge fund interest is still below average. This is a slightly negative signal and we’d rather spend our time researching stocks that hedge funds are piling on. In this regard NBIX might be a better candidate to consider taking a long position in.

Disclosure: None

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.